What is the success rate of stem cell therapy for AVN?

Answered by Stephen Mosley

The success rate of stem cell therapy for AVN (Avascular Necrosis) has shown promising results in recent studies. One particular study examined the combination of stem cell therapy and PRP-GFC (Platelet Rich Plasma-Growth Factor Concentrate) therapy in 48 patients with AVN.

In this study, the treated patients experienced significant improvement in their motor function, which is a crucial aspect of AVN treatment as it affects mobility and daily activities. This improvement in motor function can greatly enhance the quality of life for AVN patients, allowing them to regain their independence and participate in activities they were previously unable to do.

Another important finding in this study was the regrowth of cartilage in the affected joints. Cartilage regrowth ranged from 3 to 10mm, which is a considerable amount and indicates a successful regeneration process. Cartilage is essential for joint health and function, and its regrowth can help alleviate pain, improve joint stability, and prevent further deterioration.

Additionally, the patients in this study reported high satisfaction levels with the treatment. This is an important aspect to consider as patient satisfaction is a significant indicator of treatment success. When patients are satisfied with their outcomes, it suggests that the treatment has met their expectations and provided them with the desired improvements in their condition.

It is important to note that while the success rate in this particular study was high (45 out of 48 patients), individual results may vary. Each patient’s response to stem cell therapy can depend on various factors such as the severity of their AVN, their overall health, and their body’s ability to regenerate tissue.

However, these positive findings provide hope for AVN patients seeking an alternative treatment option. Stem cell therapy offers the potential for cartilage regeneration and improved motor function, which can significantly impact the quality of life for individuals with AVN.

The combination of stem cell therapy and PRP-GFC therapy has shown promising results in the treatment of AVN. The study demonstrated significant improvements in motor function, cartilage regrowth, and high patient satisfaction rates. While individual outcomes may vary, these findings offer hope for AVN patients seeking an effective and alternative treatment option.